NeurMedix, Inc., is a clinical-stage biotechnology company that engages in development of therapeutic products for the treatment of neurological diseases.
No articles found.
Recro Pharma (NASDAQ: REPH) is a revenue generating specialty pharmaceutical compa...
Recro Pharma (NASDAQ: REPH) is a revenue genera...
Join the National Investor Network and get the latest information with your interests in mind.